TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
European Drug Testing Service EDTS AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
128,446
|
125,957
|
107,918 |
Financial expenses |
106
|
137
|
427 |
Earnings before taxes |
17,713
|
4,356
|
-2,775 |
EBITDA |
16,257
|
4,601
|
-1,639 |
Total assets |
106,836
|
95,837
|
91,445 |
Current assets |
106,591
|
95,103
|
90,131 |
Current liabilities |
25,421
|
29,363
|
28,615 |
Equity capital |
79,963
|
65,990
|
62,588 |
- share capital |
345
![]() |
345
![]() |
345 |
Employees (average) |
27
![]() |
27
|
31 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
74.8%
|
68.9%
|
68.4% |
Turnover per employee |
4,757
|
4,665
|
3,481 |
Profit as a percentage of turnover |
13.8%
|
3.5%
|
-2.6% |
Return on assets (ROA) |
16.7%
|
4.7%
|
-2.6% |
Current ratio |
419.3%
|
323.9%
|
315.0% |
Return on equity (ROE) |
22.2%
|
6.6%
|
-4.4% |
Change turnover |
2,489
|
18,039
|
8,105 |
Change turnover % |
2%
|
17%
|
8% |
Chg. No. of employees |
0
|
-4
|
2 |
Chg. No. of employees % |
0%
|
-13%
|
7% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.